21-25698757-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_021219.4(JAM2):c.475G>C(p.Glu159Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000031 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021219.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JAM2 | ENST00000480456.6 | c.475G>C | p.Glu159Gln | missense_variant | Exon 5 of 10 | 1 | NM_021219.4 | ENSP00000420419.1 | ||
JAM2 | ENST00000400532.5 | c.475G>C | p.Glu159Gln | missense_variant | Exon 5 of 10 | 1 | ENSP00000383376.1 | |||
JAM2 | ENST00000312957.9 | c.367G>C | p.Glu123Gln | missense_variant | Exon 4 of 9 | 2 | ENSP00000318416.6 | |||
JAM2 | ENST00000460679.5 | n.340G>C | non_coding_transcript_exon_variant | Exon 3 of 9 | 3 | ENSP00000436801.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249574Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135406
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461860Hom.: 0 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727234
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.475G>C (p.E159Q) alteration is located in exon 5 (coding exon 5) of the JAM2 gene. This alteration results from a G to C substitution at nucleotide position 475, causing the glutamic acid (E) at amino acid position 159 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at